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13 The CFTR S737F(c.2210C>T) mutation: genotype/phenotype
correlation in seven subjects
T. Repetto1, C. Centrone2, E. Pelo2, C. Braggion1, F. Torricelli2. 1Meyer Children
Hospital, Florence, Italy; 2SOD diagnostica genetica AOU Careggi, Florence,
Italy
Background: S737F (c.2210C>T; p.Ser737Phe) is a CFTR gene missense variant
located in exon 13.
Aim: To describe the genotype/phenotype correlation of seven subjects carrying
S737F.
Material and Method: We use a 3 step strategy for the the study of CFTR gene:
Reverse Dot-blot, MLPA and direct gene sequencing, reaching 98% of detection
rate. S737F mutation was found by gene sequencing.
Results: Seven children carried S737F mutation: 5/7 were positive at neonatal
screening (NBS) and 2/7 showed hypochloremic dehydration at age of 10 and
20 months respectively. 6/7 were compound heterozygotes by showing on the other
allele F508del (3/6), 541del C, W1282X and CFTRdele 22,23,24 genotype. One
subject was S737F homozygote.
Sweat test was positive in one patient with dehydration and in one with positive
NBS: the latter had borderline sweat test, which became positive at 12 months
of age. The other children had border line values (35−60ClmEq/l). All patients
were under regular follow up (mean 4.6 yr − 1.5–10 yr). All of them had pancreas
sufﬁciency, normal BMI. Microbiological cultures from sputum were negative
or positive for Staphylococcus aureus; one child showed Pseudomonas infection
once, then eradicated. No patients had relevant respiratory symptoms or signiﬁcant
ﬁndings at chest X-ray. Mean FEV1 resulted 81% and 107% for the two older
children. The S737F homozygous patient was NBS negative, had hypochloremic
dehydration at age of 20 months, and sweat test values of 46 and 34ClmEq/L.
Conclusion: At our knowledge, this is the ﬁrst described group of subjects carrying
S737F mutation. Our ﬁndings suggest that this mutation could be associated with
mild or atypical CF phenotype.
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Background: Implementation in our routine laboratory of CFTR mRNA studies
led us to identify the intron 6b 1002–1113_1110delGAAT splicing mutation in an
adult patient having mild CF symptoms. As this mutation had also been described
in 3 other unrelated Italian CF patients, we aimed to evaluate its frequency and
phenotype/genotype correlations.
Methods: 266 unrelated patients referred to three French reference laboratories
were tested at gDNA level by sequencing: 73 classical CF, 24 questionable CF, 58
DB, 71 CBAVD and 40 CP, most of whom having a severe mutation in trans.
Results: 17 patients (13 unrelated plus 4 siblings) with various phenotypes were
found heterozygous for the mutation: 12 carried a severe mutation in trans, one was
1002–1113_1110delGAAT homozygous, one carried R117C, and two had no other
identiﬁed mutation. In total, the mutation was found in 7.3% unrelated patients with
possible CF or CFTR-RD and already carrying a mutation. Pancreatic insufﬁciency
was present in 5/16 documented cases and a positive sweat test in 9/13. The
diagnosis was delayed after 20 years in 9/16 documented cases.
Conclusion: This mutation should be considered as a CF-causing mutation with
phenotype variability and overall late diagnosis. Care should thus be taken for
genetic counselling, in particular for prenatal diagnosis. Considering its frequency,
it should be included in the second-level mutation screening.
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Objective: Slovak CF Registry was established in 1995, so that we have more
than 15 years demographics, clinical and laboratory results, data and outcome of
standard CF therapy.
Methods: Data from CF Registry were analysed for genotype/phenotype correla-
tion.
In the year 2009 there were 340 CF patients with classical form of CF and 204 pts.
with CF related disease. Data of 111 pts who died in last 42 years with increasing
mean age of death (27.6 yrs in 2009). Median age of survival is now 54.56 years.
In 186 living pts were two and in 42 pts. one CF-causing mutations detected, 1 pt
has no mutation. 8 pts with two known severe mutation in CFTR gene no clinical
ﬁndings typical for CF (F508del+H954P, F508del/Q1476X, F508/3659delC, . . . )
were found.
Conclusion: Severity of CFTR genotype is not predictive for outcome and prognosis
of CF disease in individual patients.
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The CF phenotype is very heterogeneous as a result of underlying genotypes and
modiﬁcation by genetic and environmental factors. Earlier studies showed that
the second most common CFTR mutation in the Swiss population, 3905insT, is
associated with a severe phenotype (Am J Respir Crit Care Med 2005; 171: 371;
Respir Res 2006; 7: 138). Producing a stop codon in exon 20, 3905insT transcripts
are expected to be degraded through nonsense-mediated mRNA decay. Recently,
we showed, however, that 3905insT mRNA is not degraded and 3905insT proteins
may be trapped in the ER (Eur J Hum Genet 2010;18: 212).
Aim: To look for associations between speciﬁc genotypes (F508del/F508del,
F508del/3905insT, non-F508del/3905insT) and lung parameters in order to char-
acterise the phenotypic effect of 3905insT.
Methods: Serial annual lung function measurements from 130 CF patients provided
data pertaining to pulmonary hyperinﬂation (FRCpleth), ventilation inhomogeneities
(LCI), trapped gas (VTG), airway obstruction (sReff ), and ﬂow limitation (FEV1,
FEF50). Disease progression represented by the slope of lung function related
to age was calculated by linear mixed model analysis. Signiﬁcant differences
(p< 0.001) were found between the three genotypes and all lung parameters
identifying F508del/3905insT patients as to be most severely affected whereas non-
F508del/3905insT individuals showed mildest lung disease with slow progression.
Conclusion: 3905insT per se is rather a mild mutation. The combination
F508del/3905insT, however, causes severe outcome indicating an interaction be-
tween 3905insT and F508del CFTR proteins that may prevent any transport to the
apical membrane and thus any function.
